Finasteride vs Rituximab

Finasteride vs Rituximab: Overview

This comparison examines the pharmacological differences between Finasteride and Rituximab.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Rituximab — Antibody.